Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Feng Yu Luo"'
Autor:
Xiao-Qing Qiu, Shuaiyao Lu, Ke-Fu Cao, Cheng-Yun Yang, Yanan Zhou, Jian-Yong Tang, Dong Zhang, Feng-Yu Luo, Hong-Fa Li, Rong-Qi Li
The unprecedented coronavirus disease (COVID-19) epidemic has created a worldwide public health emergency, and there is an urgent need to develop an effective antiviral drug to control this severe infectious disease. Here, we found that the E, or M m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::678f48d8f4e1dd414f9a3343eaccee6e
https://doi.org/10.21203/rs.3.rs-1475652/v1
https://doi.org/10.21203/rs.3.rs-1475652/v1
Autor:
Yu Xia, Jiong Cai, Jie Chen, Jian Guan, Feng Yu Luo, Wei Dai, Hua Ye Han, Yang Ming Liu, Tao Yang, Xuan Zeng, Xin Li, Yu Xue Dong
Publikováno v:
RNA & DISEASE.
Let-7 microRNA (miRNA) family members have been demonstrated to have potential therapeutic value in vitro and in vivo as tumor suppressors that act by regulating Ras at a posttranscriptional level. Previous studies on these miRNAs have primarily focu
Autor:
Yang Ming Liu, Yu Xia, Wei Dai, Hua Ye Han, Yu Xue Dong, Jiong Cai, Xuan Zeng, Feng Yu Luo, Tao Yang, Yuan Zhi Li, Jie Chen, Jian Guan
Publikováno v:
BMC Cancer; 2014, Vol. 14 Issue 1, p1-24, 24p, 2 Color Photographs, 1 Black and White Photograph, 2 Graphs
Autor:
Jiong Cai, Jie Chen, Yuan Zhi Li, Xuan Zeng, Yu Xia, Yang Ming Liu, Tao Yang, Jian Guan, Yu Xue Dong, Wei Dai, Hua Ye Han, Feng Yu Luo
Publikováno v:
BMC Cancer
Background A major challenge to the clinical utility of let-7 for hepatocellular carcinoma (HCC) therapy is the lack of an effective carrier to target tumours. We confirmed the high transfection efficiency of cholesterol-conjugated let-7a miRNA mimic